Burden of anemia in chronic kidney disease: beyond erythropoietin
Anemia is a frequent comorbidity of chronic kidney disease (CKD) and is associated with a
considerable burden because of decreased patient health-related quality of life and …
considerable burden because of decreased patient health-related quality of life and …
Anemia, diabetes, and chronic kidney disease
U Mehdi, RD Toto - Diabetes care, 2009 - Am Diabetes Assoc
Diabetes is the leading cause of chronic kidney disease (CKD) and is associated with
excessive cardiovascular morbidity and mortality (1, 2). Anemia is common among those …
excessive cardiovascular morbidity and mortality (1, 2). Anemia is common among those …
[HTML][HTML] Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study …
GBD 2021 Anaemia Collaborators - The Lancet Haematology, 2023 - Elsevier
Background Anaemia is a major health problem worldwide. Global estimates of anaemia
burden are crucial for developing appropriate interventions to meet current international …
burden are crucial for developing appropriate interventions to meet current international …
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
Background Anemia is associated with an increased risk of cardiovascular and renal events
among patients with type 2 diabetes and chronic kidney disease. Although darbepoetin alfa …
among patients with type 2 diabetes and chronic kidney disease. Although darbepoetin alfa …
Erythropoietic response and outcomes in kidney disease and type 2 diabetes
Background Non–placebo-controlled trials of erythropoiesis-stimulating agents (ESAs)
comparing lower and higher hemoglobin targets in patients with chronic kidney disease …
comparing lower and higher hemoglobin targets in patients with chronic kidney disease …
Impact of anemia on hospitalization and mortality in older adults
Although anemia is common in older adults, its prognostic significance is uncertain. A total of
17 030 community-dwelling subjects 66 years and older were identified between July 1 and …
17 030 community-dwelling subjects 66 years and older were identified between July 1 and …
Prevalence of anemia in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease …
T Sofue, N Nakagawa, E Kanda, H Nagasu… - PloS one, 2020 - journals.plos.org
Background The Japan Chronic Kidney Disease Database (J-CKD-DB) is a nationwide
clinical database of patients with chronic kidney disease (CKD) based on electronic health …
clinical database of patients with chronic kidney disease (CKD) based on electronic health …
Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis
BACKGROUND: Targeting higher hemoglobin levels with erythropoiesis-stimulating agents
(ESAs) to treat the anemia of chronic kidney disease (CKD) is associated with increased …
(ESAs) to treat the anemia of chronic kidney disease (CKD) is associated with increased …
Parenteral versus oral iron therapy for adults and children with chronic kidney disease
Background The anaemia seen in chronic kidney disease (CKD) may be exacerbated by
iron deficiency. Iron can be provided through different routes, with advantages and …
iron deficiency. Iron can be provided through different routes, with advantages and …
Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease
DE Weiner, S Tabatabai, H Tighiouart… - American journal of …, 2006 - Elsevier
Background: Chronic kidney disease (CKD) is a risk factor for cardiovascular disease (CVD).
Concurrently, CVD may promote CKD, resulting in a vicious cycle. We evaluated this …
Concurrently, CVD may promote CKD, resulting in a vicious cycle. We evaluated this …